Last updated: March 22, 2021
Sponsor: Galaxy Pharma (Pvt) Limited
Overall Status: Active - Recruiting
Phase
N/A
Condition
Infertility
Treatment
N/AClinical Study ID
NCT01058252
GIVF-SRM 1001
Ages 20-37 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Tubal factor without Hydrosalpinx
- Unexplained infertility with unsuccessful attempts in achieving pregnancy throughtimed intercourse or IUI
- Boarder line male factor infertility
- Sperm DNA Fragmentation < 30%
- Normal Uterine Cavity
- Normal baseline ultrasound with adequate number of primary follicles present
- Normal FSH and E2 on Day 3
- Age of the female is < 35 years old
Exclusion
Exclusion Criteria:
- If previous IVF or INVO attempts resulted in failed fertilisation
- Male partner who has difficulty in producing semen sample
- Very low sperm count, very low percentage of sperm motility and morphology
- Sperm DNA Fragmentation > 30%
- Age of female patient > 37 years
- Borderline or elevated E2 or FSH on day 3 or failed CCCT or low blood inhibin levels
- Poor ovarian response
- Hydrosalpinx
- Anatomic difficulties in reaching ovaries for oocyte retrieval
- Cervical stenosis, making embryo transfer difficult
- Uterine abnormalities or deformities
- Obesity
Study Design
Total Participants: 30
Study Start date:
May 01, 2021
Estimated Completion Date:
March 31, 2022
Study Description
Connect with a study center
Friends Ivf
Faisalabad, Punjab
PakistanSite Not Available
Lady Wallington Hospital
Lahore, Punjab
PakistanActive - Recruiting
Fertility Care Multan
Multan, Punjab
PakistanSite Not Available
Ova IVF & Reproductive Health Clinics
Karachi, Sindh 75300
PakistanActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.